Immune - Health Rising

TREATME: the Open Medicine Foundation’s Mammoth ME/CFS and Long COVID Treatment Survey Results

The Best of Times, The Worst of Times: Ian Lipkin Talks on ME/CFS

by Cort Johnson | Jul 6, 2025 | B-cells, Epstein-Barr Virus, Genetics, Gulf War Illness, Gut, Homepage, Immune, ME/CFS, Metabolism, Pathogens, Research

The famous virus hunter Ian Lipkin is very excited about progress in the ME/CFS field. Funding for his NIH-funded ME/CFS research center at Columbia University, however, has been frozen by the Trump administration.

Are Barriers to Blood Diffusion Causing ME/CFS and Long COVID? The 2025 Charité International Conference Pt I

by Cort Johnson | Jun 28, 2025 | B-cells, Cardiovascular, Complement, Connective Tissues, Endothelial Cells, Energy Production, Exercise, Homepage, Immune, long COVID, Metabolism, Muscles

Conference findings suggest multiple barriers to blood flows could be causing chronic fatigue syndrome (ME/CFS) and long COVID.

A Neuroinflammation Buster? Jarred Younger on tFUS Stimulation for ME/CFS, Fibromyalgia and long COVID

by Cort Johnson | Jun 22, 2025 | Astrocytes, Basal Ganglia, Brain, Brainstem, Homepage, Limbic System, Neuroinflammation, Neuroinflammation, Prefrontal Cortex, Research, tFUS, Treatment

Transcranial focused ultrasound (tFUS) may be able to reach deep enough in the brain to help people with fibromyalgia, ME/CFS and long COVID.

Did a Lab Study Just Uncover a Craniocervical Instability Subset in ME/CFS?

by Cort Johnson | Jun 15, 2025 | Astrocytes, Connective Tissues, Craniocervical Instability, Cytokines, Fibromyalgia and Pain, Homepage, Inflammation, Matrix metalloproteinases, Monocytes, Neuroinflammation, Neuroinflammation, Research

A cerebral spinal fluid study finds a cluster of ME/CFS patients who may have spinal issues including craniocervical instability.

Immune Dysregulation Could be the Tipping Point for Long COVID

by Cort Johnson | Jun 11, 2025 | Baritcinib, COVID-19, Cytokines, Drugs, Gut, Homepage, Immune, Inflammation, long COVID, Metformin, Microbiome, Monocytes, Oxidative Stress, Rapamycin, Research, T-cells, Treatment

Profound immune dysregulation could be the tipping point that turns a COVID-19 patient into a long COVID patient.

The GLP1 Agonists: An Exciting New Class of Drugs For ME/CFS, FM and Long COVID?

by Cort Johnson | May 28, 2025 | GLP-1, Homepage, Inflammation, Kaufman, long COVID, Mast cell activation syndrome, Mast cell activation syndrome, Metabolism, Microbiome, Neuroinflammation, Ruhoy

GLP-1 agonists like Ozempic could be surprisingly helpful in diseases like chronic fatigue syndrome, fibromyalgia and long COVID.

« Older Entries

Health Rising’s Quickie Summer Donation Drive

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Lives Interrupted

Lives Interrupted Latest Story

Entire Adulthood taken from me

Megan

Randolph, United States

Former occupation: Day care worker

Total Economic Losses:

$562,824

Lives Interrupted Stats

Number of Stories: 46

Years of Work Lost: 347

Average Total Economic Losses:

$874,073

Total Economic Losses:

$28,844,414

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

Keep the information flowing! Support Health Rising during our quickie Summer Donation Drive!Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

TREATME: the Open Medicine Foundation’s Mammoth ME/CFS and Long COVID Treatment Survey Results

The Best of Times, The Worst of Times: Ian Lipkin Talks on ME/CFS

Are Barriers to Blood Diffusion Causing ME/CFS and Long COVID? The 2025 Charité International Conference Pt I

A Neuroinflammation Buster? Jarred Younger on tFUS Stimulation for ME/CFS, Fibromyalgia and long COVID

Did a Lab Study Just Uncover a Craniocervical Instability Subset in ME/CFS?

Immune Dysregulation Could be the Tipping Point for Long COVID

The GLP1 Agonists: An Exciting New Class of Drugs For ME/CFS, FM and Long COVID?

Health Rising’s Quickie Summer Donation Drive

Subscribe

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest